Cargando…
Prevalence of Dyslipidemia in Patients With Type 2 Diabetes Mellitus: A Cross-Sectional Study
Introduction: Diabetes mellitus (DM), a chronic metabolic noncommunicable disease (NCD), has assumed epidemic proportions worldwide. Type 2 diabetes (T2D) is defined as chronic high blood glucose levels due to the deficiency of insulin or resistance to it. Dyslipidemia is one of the major causes of...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733631/ https://www.ncbi.nlm.nih.gov/pubmed/35004041 http://dx.doi.org/10.7759/cureus.20222 |
_version_ | 1784627840712441856 |
---|---|
author | Al Ghadeer, Hussain A Al Barqi, Mohammed Almaqhawi, Abdullah Alsultan, Amal S Alghafli, Jinan A AlOmaish, Murtada A AlGhanem, Zuhur A Alsaqar, Amer H Alatiyyah, Abrar T Alburayh, Yasamiyan A AlOmair, Abdulatif Almuhaysin, Afaf I Alsaeed, Ali A |
author_facet | Al Ghadeer, Hussain A Al Barqi, Mohammed Almaqhawi, Abdullah Alsultan, Amal S Alghafli, Jinan A AlOmaish, Murtada A AlGhanem, Zuhur A Alsaqar, Amer H Alatiyyah, Abrar T Alburayh, Yasamiyan A AlOmair, Abdulatif Almuhaysin, Afaf I Alsaeed, Ali A |
author_sort | Al Ghadeer, Hussain A |
collection | PubMed |
description | Introduction: Diabetes mellitus (DM), a chronic metabolic noncommunicable disease (NCD), has assumed epidemic proportions worldwide. Type 2 diabetes (T2D) is defined as chronic high blood glucose levels due to the deficiency of insulin or resistance to it. Dyslipidemia is one of the major causes of cardiovascular diseases in patients with T2D. It is characterized by elevated plasma triglyceride (TG), low high-density lipoprotein (HDL) cholesterol, and high low-density lipoprotein (LDL) cholesterol, which is mostly present in patients with DM. Methods: We conducted a retrospective cross-sectional study at the King Faisal University (KFU) Health Center in the eastern region of Saudi Arabia. The data of patients from October 2014 to February 2021 were collected. We collected the patients’ data from the KFU Health Center after obtaining approval from the KFU polyclinic administration. Prior ethical approval was taken from the Institutional Review Board of Ethics and Research Committee in the College of Medicine, KFU (approval number, 2020-10-62). We collected patients’ data, including their gender, age, nationality, and blood analysis (lipids profile - TGs, HDL, LDL, and hemoglobin A1c [HbA1c] levels). Result: This study included 191 patients with T2D, 137 (71.7%) were from Saudi Arabia, and 54 (28.3%) were from other countries. Patients’ age ranged from 21 to 100 years, with a mean age of 56.2 ± 11.8 years. There were 107 (56%) females. Cholesterol levels ranged from 102 to 300 mg/dl with a mean value of 187.3 mg/dl. Conclusion: In the current study, we assessed the association between HbA1c levels and lipid profiles in patients with T2D at the KFU Health Center in the eastern region of the Kingdom of Saudi Arabia. Our results on the adjusted relationship of HbA1c with lipid profile through regression model have demonstrated that HDL alone had significant adjusted relation with HbA1c if other factors are kept constant. We suggest focusing on TC and HDL levels in T2D health management in future studies. |
format | Online Article Text |
id | pubmed-8733631 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-87336312022-01-08 Prevalence of Dyslipidemia in Patients With Type 2 Diabetes Mellitus: A Cross-Sectional Study Al Ghadeer, Hussain A Al Barqi, Mohammed Almaqhawi, Abdullah Alsultan, Amal S Alghafli, Jinan A AlOmaish, Murtada A AlGhanem, Zuhur A Alsaqar, Amer H Alatiyyah, Abrar T Alburayh, Yasamiyan A AlOmair, Abdulatif Almuhaysin, Afaf I Alsaeed, Ali A Cureus Endocrinology/Diabetes/Metabolism Introduction: Diabetes mellitus (DM), a chronic metabolic noncommunicable disease (NCD), has assumed epidemic proportions worldwide. Type 2 diabetes (T2D) is defined as chronic high blood glucose levels due to the deficiency of insulin or resistance to it. Dyslipidemia is one of the major causes of cardiovascular diseases in patients with T2D. It is characterized by elevated plasma triglyceride (TG), low high-density lipoprotein (HDL) cholesterol, and high low-density lipoprotein (LDL) cholesterol, which is mostly present in patients with DM. Methods: We conducted a retrospective cross-sectional study at the King Faisal University (KFU) Health Center in the eastern region of Saudi Arabia. The data of patients from October 2014 to February 2021 were collected. We collected the patients’ data from the KFU Health Center after obtaining approval from the KFU polyclinic administration. Prior ethical approval was taken from the Institutional Review Board of Ethics and Research Committee in the College of Medicine, KFU (approval number, 2020-10-62). We collected patients’ data, including their gender, age, nationality, and blood analysis (lipids profile - TGs, HDL, LDL, and hemoglobin A1c [HbA1c] levels). Result: This study included 191 patients with T2D, 137 (71.7%) were from Saudi Arabia, and 54 (28.3%) were from other countries. Patients’ age ranged from 21 to 100 years, with a mean age of 56.2 ± 11.8 years. There were 107 (56%) females. Cholesterol levels ranged from 102 to 300 mg/dl with a mean value of 187.3 mg/dl. Conclusion: In the current study, we assessed the association between HbA1c levels and lipid profiles in patients with T2D at the KFU Health Center in the eastern region of the Kingdom of Saudi Arabia. Our results on the adjusted relationship of HbA1c with lipid profile through regression model have demonstrated that HDL alone had significant adjusted relation with HbA1c if other factors are kept constant. We suggest focusing on TC and HDL levels in T2D health management in future studies. Cureus 2021-12-06 /pmc/articles/PMC8733631/ /pubmed/35004041 http://dx.doi.org/10.7759/cureus.20222 Text en Copyright © 2021, Al Ghadeer et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Endocrinology/Diabetes/Metabolism Al Ghadeer, Hussain A Al Barqi, Mohammed Almaqhawi, Abdullah Alsultan, Amal S Alghafli, Jinan A AlOmaish, Murtada A AlGhanem, Zuhur A Alsaqar, Amer H Alatiyyah, Abrar T Alburayh, Yasamiyan A AlOmair, Abdulatif Almuhaysin, Afaf I Alsaeed, Ali A Prevalence of Dyslipidemia in Patients With Type 2 Diabetes Mellitus: A Cross-Sectional Study |
title | Prevalence of Dyslipidemia in Patients With Type 2 Diabetes Mellitus: A Cross-Sectional Study |
title_full | Prevalence of Dyslipidemia in Patients With Type 2 Diabetes Mellitus: A Cross-Sectional Study |
title_fullStr | Prevalence of Dyslipidemia in Patients With Type 2 Diabetes Mellitus: A Cross-Sectional Study |
title_full_unstemmed | Prevalence of Dyslipidemia in Patients With Type 2 Diabetes Mellitus: A Cross-Sectional Study |
title_short | Prevalence of Dyslipidemia in Patients With Type 2 Diabetes Mellitus: A Cross-Sectional Study |
title_sort | prevalence of dyslipidemia in patients with type 2 diabetes mellitus: a cross-sectional study |
topic | Endocrinology/Diabetes/Metabolism |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733631/ https://www.ncbi.nlm.nih.gov/pubmed/35004041 http://dx.doi.org/10.7759/cureus.20222 |
work_keys_str_mv | AT alghadeerhussaina prevalenceofdyslipidemiainpatientswithtype2diabetesmellitusacrosssectionalstudy AT albarqimohammed prevalenceofdyslipidemiainpatientswithtype2diabetesmellitusacrosssectionalstudy AT almaqhawiabdullah prevalenceofdyslipidemiainpatientswithtype2diabetesmellitusacrosssectionalstudy AT alsultanamals prevalenceofdyslipidemiainpatientswithtype2diabetesmellitusacrosssectionalstudy AT alghaflijinana prevalenceofdyslipidemiainpatientswithtype2diabetesmellitusacrosssectionalstudy AT alomaishmurtadaa prevalenceofdyslipidemiainpatientswithtype2diabetesmellitusacrosssectionalstudy AT alghanemzuhura prevalenceofdyslipidemiainpatientswithtype2diabetesmellitusacrosssectionalstudy AT alsaqaramerh prevalenceofdyslipidemiainpatientswithtype2diabetesmellitusacrosssectionalstudy AT alatiyyahabrart prevalenceofdyslipidemiainpatientswithtype2diabetesmellitusacrosssectionalstudy AT alburayhyasamiyana prevalenceofdyslipidemiainpatientswithtype2diabetesmellitusacrosssectionalstudy AT alomairabdulatif prevalenceofdyslipidemiainpatientswithtype2diabetesmellitusacrosssectionalstudy AT almuhaysinafafi prevalenceofdyslipidemiainpatientswithtype2diabetesmellitusacrosssectionalstudy AT alsaeedalia prevalenceofdyslipidemiainpatientswithtype2diabetesmellitusacrosssectionalstudy |